Transplantation of hematopoietic stem cells (HSCs) has been successfully developed as a
part of treatment protocols for a large number of clinical indications, and cryopreservation of …

Background: Dimethyl sulfoxide (DMSO) has been used for medical treatment and as a
pharmacological agent in humans since the 1960s. Today, DMSO is used mostly for …

Preservation of adult stem cells pools is critical for maintaining tissue homeostasis into old
age. Exhaustion of adult stem cell pools as a result of deranged metabolic signaling …

Haematopoietic stem cell transplantation (HCT) is the treatment of choice for defined
malignant and non‐malignant haematological disorders. The main drawbacks of HCT are …

Introduction: Mesenchymal stem cells (MSC) and MSC-like cells hold great promise and
offer many advantages for developing effective cellular therapeutics. Current trends indicate …

A retrospective review of the published literature identified several hundred adverse
reactions (eg nausea, chills, cardiac arrhythmias, neurological symptoms and respiratory …

BACKGROUND: Autologous stem cell transplantation with cryopreserved autografts is a
prerequisite for high‐dose chemotherapy in treatment of several malignancies. Adverse …

Background aims Infusion of stem cell autografts can be associated with adverse effects.
Necrotic normal leukocytes, cytokines or intracellular mediators released from leukocytes …

BACKGROUND Autologous hematopoietic stem cell (HSC) transplantation has been used
for almost three decades for the management of malignant hematologic diseases and some …

Background and Objectives The infusion of thawed haematopoietic progenitor cells from
apheresis (HPC‐A) is associated with minor but frequent adverse reactions (ARs), which …